Wiley Interdisciplinary Reviews_ Systems Biology and Medicine

Wiley Interdisciplinary Reviews_ Systems Biology and Medicine (commonly abbreviated as Wiley Interdiscip. Rev. Syst. Biol. Med.) was a reviews journal of systems biology and systems medicine published by John Wiley & Sons. Launched in 2009, it ceased publication at the end of 2020.Wiley Interdisciplinary Reviews_ Systems Biology and Medicine（常用缩写 Wiley Interdiscip. Rev. Syst. Biol. Med.）是 John Wiley & Sons 出版的系统生物学与系统医学综述期刊，2009 年创刊，2020 年底停刊。^[1]

Scope

• Series character: part of the Wiley Interdisciplinary Reviews series, the journal combined the strengths of encyclopedic reference works and review journals as evolving online databases of cutting-edge reviews.学科定位： 期刊属于威利跨学科评论系列，该系列结合百科参考书与综述期刊的特点，以不断演进的在线数据库形态呈现前沿综述。
• Subject coverage: the journal promoted cross-disciplinary discussion of systems concepts in the life sciences and medicine, addressing key topics from the perspectives of medicine, biology, physiology, computational biology and modelling, and bioengineering.收录主题： 期刊旨在促进生命科学与医学中系统概念的跨学科讨论，内容从医学、生物学、生理学、计算生物学与建模以及生物工程等视角展开。
• Article form: in line with the series, articles revolved around biology, methods and models, spanning systems from a few molecules to whole species.体裁： 与系列其他刊一致，文章围绕生物学、方法与模型展开，综述覆盖从少数分子到整个物种的系统。
• Indexing and metrics: indexed in the Science Citation Index Expanded, the journal carried a 2022 impact factor of 7.9 with a CiteScore of 18.4.收录与指标： 期刊被科学引文索引扩展版收录，2022 年影响因子为 7.9，CiteScore 达 18.4。^[2]

History

• Founded in 2009: the first issue, volume 1 number 1, appeared in July and August 2009 under the Wiley-Blackwell imprint.2009年创刊： 期刊于 2009 年 7 至 8 月出版第 1 卷第 1 期，由 Wiley-Blackwell 出版。
• Frequency: six issues a year were published from 2010 onward.刊期： 自 2010 年起每年出版六期。
• Discontinuation and merger: the journal ended with volume 12 number 6 in November and December 2020, merging with two other WIREs titles into WIREs Mechanisms of Disease.停刊与合并： 期刊于 2020 年 11 至 12 月出至第 12 卷第 6 期后停刊，与威利跨学科评论系列的其他两刊合并为 WIREs Mechanisms of Disease。^[3]
• Recent metrics: the impact factor stood at 3.709 in 2017, 5.0 in 2020 and 7.9 in 2022.近年指标： 影响因子 2017 年为 3.709，2020 年为 5.0，2022 年为 7.9。

Editors

• Editors-in-chief: the journal was co-led by Joseph H. Nadeau of the Pacific Northwest Research Institute and Shankar Subramaniam of the University of California, San Diego.主编： 期刊由 Joseph H. Nadeau 与 Shankar Subramaniam 联合主持，分别来自太平洋西北研究所与加州大学圣迭戈分校。
• Editorial board: the board gathered leading figures of systems biology, including Russ Altman of Stanford, Shu Chien of UC San Diego, Garret FitzGerald of Penn and Peter Hunter of Auckland.编委构成： 编委会汇聚斯坦福大学的 Russ Altman、加州大学圣迭戈分校的 Shu Chien、宾夕法尼亚大学的 Garret FitzGerald、奥克兰大学的 Peter Hunter 等系统生物学代表人物。
• Submission and peer review: manuscripts were lodged through an online system and refereed, with some content commissioned.投稿与评审： 稿件经在线系统递交，接受同行评审，部分稿件由编辑部约稿。^[4]
• Editorial policy: systems thinking across the life sciences and medicine was the thread, bringing quantitative analysis and modelling into clinical context.编辑方针： 期刊强调系统概念在生命科学与医学中的贯通，鼓励定量分析与建模进入临床语境。
• Afterlife: the merged successor title carried the journal's themes onward, with back volumes remaining searchable on the publisher platform.停刊后去向： 期刊停刊后其主题由合并后的新刊继续承载，历史各卷在出版方平台可查。